OXLD1
Oxidoreductase-like domain-containing protein 1
Also known as: C17orf90, MGC104712, OXLD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5BKU9
- Gene
- OXLD1
- Ensembl
- ENSG00000204237
- Chromosome
- 17
- Canonical length
- 147 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
Located in mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>Q5BKU9|OXLD1
1 MLLRRVVEGG RAVAAAVRGS GARRFSSPDC CQRLPGGGSF LQRHHPGAQA PDGRRKFGTD
61 HVEVGSQAGA DGTRPPKASL PPELQPPTNC CMSGCPNCVW VEYADRLLQH FQDGGERALA
121 ALEEHVADEN LKAFLRMEIR LHTRCGGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OXLD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- testis: 29 nTPM
- liver: 18 nTPM
- skeletal muscle: 17 nTPM
- adrenal gland: 16 nTPM
- basal ganglia: 16 nTPM
- amygdala: 15 nTPM
Single-cell type
- late primary spermatocytes: 191 nCPM
- epididymal principal cells: 83 nCPM
- esophageal apical cells: 80 nCPM
- esophageal suprabasal cells: 73 nCPM
- early spermatids: 69 nCPM
- esophageal basal cells: 63 nCPM
Immune cell
- NK-cell: 36 nTPM
- naive CD4 T-cell: 34 nTPM
- memory CD4 T-cell: 32 nTPM
- plasmacytoid DC: 31 nTPM
- T-reg: 31 nTPM
- naive B-cell: 29 nTPM
Brain region
- white matter: 9.4 nTPM
- spinal cord: 8.7 nTPM
- thalamus: 8.7 nTPM
- hypothalamus: 8.6 nTPM
- medulla oblongata: 8.6 nTPM
- cerebral cortex: 8.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0.27
- gnomAD missense Z
- -0.3
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Oxidoreductase-like, N-terminal
- Oxidoreductase-like protein, N-terminal
- Oxidoreductase-like domain-containing protein 1
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OXLD1 as an antibody target. Whether an autoantibody or antibody against OXLD1 could matter depends on whether native OXLD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OXLD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OXLD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...